4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-N-[(4-methylphenyl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-N-[(4-methylphenyl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-N-[(4-methylphenyl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Compound characteristics
| Compound ID: | L310-3213 |
| Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-N-[(4-methylphenyl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide |
| Molecular Weight: | 482.56 |
| Molecular Formula: | C24 H26 N4 O5 S |
| Smiles: | Cc1ccc(CNS(c2cc3c(cc2C)N(Cc2nc(C4CCC4)on2)C(CO3)=O)(=O)=O)cc1 |
| Stereo: | ACHIRAL |
| logP: | 3.5404 |
| logD: | 3.5397 |
| logSw: | -3.7794 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 99.018 |
| InChI Key: | GFIRSZMUWIYDMD-UHFFFAOYSA-N |